✨ Your Portfolio is fetched and updated from zerodha.
Nano
Market Cap
₹102 Cr.
P/E
27.12

Key Ratios

Market cap
Market cap
102 Cr
PE
PE
27.12
Prom Holding
Prom Holding
73.66 %
ROE (%)
ROE (%)
5.87
ROCE (%)
ROCE (%)
8.81
Div Yield (%)
Div Yield (%)
-
Sales
Sales
76.56 Cr
OPM (%)
OPM (%)
10.14 %
Debt to Equity
Debt to Equity
0.08
About
Mercury Laboratories Ltd. is a pharmaceutical company and is established in the year 1952 .The… Read more
Low
805
52W Range
High
880
  • Mercury Laboratories
  • Samrat Pharmachem
  • Rajnish Wellness

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on Mercury Laboratories Ltd. Business

Mercury Laboratories Ltd., established in 1952, is a leading pharmaceutical company specializing in gynecology, cardiovascular, multivitamins, antibiotics, pain management, and gastroenterology. Their focus is on mother and child care products.

Mercury Laboratories major competitors are Samrat Pharmachem, Rajnish Wellness, Bharat Immunological, Amwill Health Care, Source Natural Foods, Makers Laboratories, Onyx Biotec.
Market Cap of Mercury Laboratories is ₹102 Crs.
While the median market cap of its peers are ₹94 Crs.

Mercury Laboratories seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material